Skip to content

Influence of the package name on the efficacy of open label placebos (OLPs) for sadness

Influence of the package name on the efficacy of open label placebos (OLPs) for sadness

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
DRKS
Registry ID
DRKS00035902
Enrollment
150
Registered
2025-01-14
Start date
2025-02-19
Completion date
Unknown
Last updated
2025-10-06

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Healthy participants

Interventions

Group 1: OLP+Name: Open Label Placebo with an invented “pharmacological-sounding” name for the OLP Group 2: OLP name: Open Label Placebo without product name on the label (only “Placebo”) Group 3: Con

Sponsors

Universität Graz
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to No maximum

Inclusion criteria

Inclusion criteria: No other specific inclusion criteria

Exclusion criteria

Exclusion criteria: severe psychiatric disorder (e.g. psychotic disorders)

Design outcomes

Primary

MeasureTime frame
Item ratings (before and after presenting the pictures): - How sad do you feel right now? (0-100) - How lonely do you feel right now? (0-100) - How excited do you feel right now? (0-100) - How distressed do you feel right now? (0-100)

Secondary

MeasureTime frame
In the first part of the study, the following questionnaires and items are presented to the participants once in an online survey: - Brief Symptom Inventory (BSI-18; Franke, G. H., 2000) - UCLA Loneliness Scale (Döring & Bortz, 1993) - NEO Five Factor Inventory (NEO-FFI; Borkenau & Ostendorf, 2007) - 5 items on brand attitude: 1. A brand name is an important source of information about the quality of a product. 2. The brand name of a product influences my purchase decision. 3. I trust branded products. 4. with branded products, you know what you are getting. 5. if I own a branded product, I feel better.

Countries

Austria

Contacts

Public ContactAnne Schienle

Universität Graz

anne.schienle@uni-graz.at+43 316 380 5086

Outcome results

None listed

Source: DRKS (via WHO ICTRP) · Data processed: Feb 4, 2026